Botulinum toxin type A applications for masticatory myofascial pain and trigeminal neuralgia: what is the evidence regarding adverse effects?

Giancarlo De la Torre CanalesRodrigo Lorenzi PoluhaVictor Muñoz LoraDyna Mara Araújo Oliveira FerreiraJuliana Stuginski-BarbosaLeonardo Rigoldi BonjardimAltair Antoninha Del Bel CuryPaulo César Rodrigues Conti

Published in: Clinical oral investigations (2019)

BoNT-A has been increasingly diffused in dentistry, being used for the management of masticatory myofascial pain and trigeminal neuralgia. Nonetheless, there is no consensus about its efficacy and adverse effects that could occur when this treatment is applied.

Keyphrases

botulinum toxin
neuropathic pain
chronic pain
pain management
spinal cord
spinal cord injury
combination therapy